Status: Recruiting
SY001 Targets Mesothelin in a Single-arm, Dose-increasing Setting in Subjects With Advanced Solid Tumors
Single-arm, dose-increasing setting study of CAR macrophages in Mesothelin overexpressing solid tumors.
Participants needed: 2
Trial details
Age: 18-75Biological sex: FemaleType: InterventionalSponsor: Cell Origin Biotech (Hangzhou) Co., Ltd.Updated: Feb 13, 2026Locations: 2
Eligibility criteria
Patients with pathologically diagnosed advanced ovarian cancer/pancreatic cancer... [+4]
Pregnant or lactating women; [+4]